General MedicationsOPHTHALMICStandard

BRIMONIDINE TARTRATE

Standard Dose

0.2%

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview BRIMONIDINE TARTRATE is listed in Drugs@FDA under application 217846 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BRIMONIDINE TARTRATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.2% Sponsor MICRO LABS Submission history Latest submission status date: 2023-11-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview BRIMONIDINE TARTRATE is listed in Drugs@FDA under application 217846 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BRIMONIDINE TARTRATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.2% Sponsor MICRO LABS Submission history Latest submission status date: 2023-11-22 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.